Were the Labcorp (LH) EVP’s share sales made under a Rule 10b5-1 plan?

Yes. A footnote explains the sale was made pursuant to a plan established in accordance with Rule 10b5-1 under the Securities Exchange Act. Such pre-arranged plans allow insiders to sell shares on a set schedule, reducing timing-related concerns.

Labcorp (LH) EVP gets performance shares, sells portion under 10b5-1 plan

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

LABCORP HOLDINGS INC. executive vice president of operations Jonathan C. Meltzer reported a mix of equity compensation and routine share sales. On March 26, 2026, he acquired 2,388 shares of common stock at no cost through a performance award tied to results for the three-year period ended December 31, 2025. That same day, 711 shares were withheld to cover tax obligations. On March 27, 2026, he conducted an open-market sale of 839 shares at $267.05 per share under a pre-arranged Rule 10b5-1 trading plan. After these transactions, he directly holds 3,620.3256 shares of Labcorp common stock.

Insider Trade Summary 10b5-1

Net Seller: 839 shares ($224,055)

Net Sell 3 txns

Insider Meltzer Jonathan C

Role EVP, Operations

Sold 839 shs ($224K)

Type	Security	Shares	Price	Value
Sale	Common Stock	839	$267.05	$224K
Grant/Award	Common Stock	2,388	$0.00	--
Tax Withholding	Common Stock	711	$268.38	$191K

Holdings After Transaction: Common Stock — 3,620.326 shares (Direct)

Footnotes (1)

Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025. Stock withholding to satisfy tax withholding obligations. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Key Figures

Open-market sale: 839 shares at $267.05 Performance award shares: 2,388 shares Tax withholding shares: 711 shares at $268.38 +3 more

6 metrics

Open-market sale 839 shares at $267.05 Common stock sale on March 27, 2026

Performance award shares 2,388 shares Award relating to three-year period ended December 31, 2025

Tax withholding shares 711 shares at $268.38 Shares withheld to satisfy tax obligations on March 26, 2026

Post-transaction holdings 3,620.3256 shares Directly owned Labcorp common stock after reported transactions

Pre-sale holdings 4,459.3256 shares Direct holdings after tax withholding and before March 27 sale

Post-award holdings 5,170.3256 shares Direct holdings immediately after 2,388-share performance award

Key Terms

performance award, tax withholding obligations, Rule 10b5-1, open-market sale, +1 more

5 terms

performance award financial

"pursuant to a performance award granted on February 7, 2023, relating to performance"

tax withholding obligations financial

"Stock withholding to satisfy tax withholding obligations."

Rule 10b5-1 regulatory

"Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Form 4 Insider Transactions: What Each Field Means →

03/30/2026 - 12:44 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Meltzer Jonathan C

(Last)

(First)

(Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON

NORTH CAROLINA

27215

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Operations

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/26/2026		A⁽¹⁾		2,388	A	$0	5,170.3256	D
Common Stock	03/26/2026		F⁽²⁾		711	D	$268.38	4,459.3256	D
Common Stock	03/27/2026		S⁽³⁾		839	D	$267.05	3,620.3256	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.

2. Stock withholding to satisfy tax withholding obligations.

3. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Jonathan C. Meltzer	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Labcorp (LH) EVP Jonathan Meltzer report?

Jonathan Meltzer reported a performance-based share award, related tax withholding, and a small open-market sale. He received 2,388 common shares, had 711 shares withheld for taxes, and sold 839 shares, ending with 3,620.3256 shares held directly.

How many Labcorp (LH) shares did the EVP sell and at what price?

He sold 839 Labcorp common shares in an open-market transaction at $267.05 per share. The sale occurred on March 27, 2026, and was executed under a pre-arranged Rule 10b5-1 trading plan disclosed in the filing footnotes.

What type of equity award did the Labcorp (LH) EVP receive?

He received 2,388 Labcorp common shares pursuant to a performance award. The award, granted on February 7, 2023, related to company performance over the three-year period that ended on December 31, 2025, and was settled in shares on March 26, 2026.

Why were 711 Labcorp (LH) shares withheld from the EVP’s award?

The filing states 711 shares were withheld to satisfy tax withholding obligations. This tax-withholding disposition is coded as an F transaction, meaning the shares were used to cover taxes owed on the equity award, not sold on the open market.

How many Labcorp (LH) shares does Jonathan Meltzer hold after these transactions?

After the grant, tax withholding, and subsequent sale, he directly holds 3,620.3256 Labcorp common shares. This figure reflects his updated ownership position following the March 26, 2026 equity award and the March 27, 2026 open-market sale.